News
ESOU21 Virtual: Onco-urology updates and innovations you need to know
By Prof. Morgan Rouprêt From 29 to 31 January 2021, the 18th Meeting of the EAU Section of Oncological Urology (ESOU21 Virtual) will provide you with the most relevant onco-urology updates and contemporary insights on genitourinary cancers, making the...
New developments in imaging have great potential to change treatment in the coming years
There are several promising imaging techniques on the horizon, with the potential of changing the way oncology experts treat their patients. Novel modalities in ultrasound, combined with machine learning, further evolution of PET-CT beyond PSMA, the use of nanoparticles...
EMUC20: Highlights in GU cancers
Active surveillance should be considered the first treatment for prostate cancer in order to ensure the best quality of life. This was one of the key messages of Mr. André Deschamps’ (BE) presentation during the “Highlights in GU cancers”...
EMUC19: ARAMIS trial likely to change Guidelines recommendations
The third day of the EMUC meeting (and the second day of the main scientific programme) opened with a two-hour session on new trials. Like all sessions at EMUC19, it was chaired by a multidisciplinary group, in this case...
ESOU20 to unveil GU fundamentals in Dublin
By Prof. Morgan Rouprêt, ESOU Chairman Expect a wide-range, accurate overview of current novelties in onco-urology at 17th Meeting of the EAU Section of Oncological Urology (ESOU20). Join us in Dublin, Ireland from 17 to 19 January 2020 for...
PCa19: Two days of total immersion in all the latest treatment options for prostate cancer
Participants of PCa19 can expect two days of immersion in all the latest treatment options for prostate cancer, says Prof. Steven Joniau (Leuven, BE), member of the PCa19 Scientific Committee and one of the faculty members. Now in its...
EAU uniquely placed to help European urologists’ ambitions
Every year, the EAU meets with representatives from Europe’s national urological societies in Noordwijk, on the Dutch coast, for a discussion on how the EAU and the societies can help each other raise urological care across the continent. Topics...
New ESOU Chairman talks about aims & current onco-urology challenges
We interviewed the new Chairman of the EAU Section of Oncological Urology (ESOU), Prof. Morgan Rouprêt (FR), who shared his vision for the ESOU, his insights on the current challenges in onco-urology and the possible breakthroughs in the coming...
EMUC18: Updates on notable trials
Developments of notable trials were announced today during Plenary Session 06 New trials update: What we need to know which was chaired by Dr. Laurence Colette (BE), Dr. Ganesh Palapattu (US), Dr. Stephen Boorjian (US) and Dr. Alberto Bossi (FR). In his...
New EAU Policy Briefing on Kidney Cancer
As one of the most lethal genitourinary cancers, a greater recognition of kidney cancer as a European healthcare problem is a principal requirement. During the Kidney Cancer Europe Roundtable organised by the International Centre for Parliamentary Studies (ICPS), caregivers,...
ESOU19 aims to strengthen onco-urology global community
New technologies and developments in diagnosis, treatment and follow-up in prostate, bladder, renal, testicular and penile cancers are some of the topics to look forward to at the 16th Meeting of the EAU Section of Oncological Urology (ESOU19). The...
ESOU17: “Game changer ahead” in lymph node staging detection
Emerging research presented at ESOU17 showed encouraging results on the use of PSMA-PET for the diagnosis of lymph node staging. However, Prof. Markus Graefen (Hamburg, DE) did start his talk by reminding the audience on day two of ESOU17 that...